IPERIONX Secures US$12.7M DoD Grant for US Titanium Production
Ticker: IPX · Form: 6-K · Filed: Jan 31, 2024 · CIK: 1898601
| Field | Detail |
|---|---|
| Company | Iperionx LTD (IPX) |
| Form Type | 6-K |
| Filed Date | Jan 31, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | bullish |
Complexity: simple
Sentiment: bullish
Topics: government-grant, defense-contract, titanium-production, strategic-materials
TL;DR
**IPERIONX just landed a US$12.7M DoD grant for titanium, big win for their US operations.**
AI Summary
IperionX Ltd. (IPX) received a significant US$12.7 million grant from the U.S. Department of Defense (U.S. DoD) on January 30, 2024, to boost domestic titanium production. This funding, awarded under the Defense Production Act (DPA) Title III, aims to strengthen the U.S. titanium supply chain, which is crucial for national security. For investors, this grant signals strong government backing and potential for future contracts, de-risking IperionX's growth strategy and validating its titanium metal technologies.
Why It Matters
This grant provides substantial non-dilutive funding and validates IperionX's technology, positioning it as a key player in the critical U.S. titanium supply chain.
Risk Assessment
Risk Level: low — The filing reports a significant grant, which is a positive development that reduces financial risk and enhances credibility.
Analyst Insight
A smart investor would view this grant as a strong positive signal, indicating government confidence in IperionX's technology and its strategic importance. This could lead to further de-risking and potential for future growth, making it worth considering for a long-term position.
Key Numbers
- $12.7 million — U.S. Department of Defense grant (funding awarded to IperionX for domestic titanium production)
Key Players & Entities
- IperionX Limited (company) — registrant and recipient of the grant
- U.S. Department of Defense (company) — awarded the US$12.7 million grant
- Gregory Swan (person) — Secretary who signed the 6-K filing
- US$12.7 million (dollar_amount) — amount of the U.S. Department of Defense grant
Forward-Looking Statements
- IperionX will likely secure additional government contracts or grants related to critical material production. (IperionX Limited) — medium confidence, target: within 12-24 months
- The U.S. domestic titanium supply chain will see increased investment and development. (U.S. Department of Defense) — high confidence, target: within 24 months
FAQ
What is the primary purpose of the US$12.7 million grant awarded to IperionX?
The US$12.7 million grant from the U.S. Department of Defense is intended to address U.S. titanium supply chain vulnerabilities by supporting domestic titanium production, specifically IperionX's titanium metal technologies.
Under which authority was the U.S. Department of Defense grant awarded?
The U.S. Department of Defense grant was awarded under the Defense Production Act (DPA) Title III authorities.
When was the quarterly report for the period ended December 31, 2023, provided by IperionX?
IperionX provided its quarterly report for the period ended December 31, 2023, on January 30, 2024, as stated in the press release.
Who signed the Form 6-K on behalf of IperionX Limited and what is their title?
The Form 6-K was signed by Gregory Swan, who holds the title of Secretary for IperionX Limited, on January 31, 2024.
What was the previous name of IperionX Limited before its name change?
The former company name was Hyperion Metals Ltd, with the name change occurring on December 10, 2021.
Filing Stats: 149 words · 1 min read · ~1 pages · Grade level 14.2 · Accepted 2024-01-31 17:24:26
Filing Documents
- ef20020184_6k.htm (6-K) — 8KB
- ef20020184_ex99-1.htm (EX-99.1) — 155KB
- image00011.jpg (GRAPHIC) — 5KB
- image00012.jpg (GRAPHIC) — 38KB
- image00013.jpg (GRAPHIC) — 51KB
- 0001140361-24-004917.txt ( ) — 296KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 Date: January 30, 2024 Commission File Number: 001-41338 IperionX Limited (Translation of registrant's name into English) 129 W Trade Street, Suite 1405 Charlotte, North Carolina (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F EXHIBIT INDEX The following exhibits are filed as part of this Form 6-K: Exhibit Description 99.1 Press Release SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IPERIONX LIMITED (registrant) Date: January 31, 2024 By: /s/ Gregory Swan Name: Gregory Swan Title: Secretary